26 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation … and the registrar for the Ordinary Shares or the ADSs (x) the filing and other fees incident to any review by FINRA of the terms of the sale
424B3
xu0dkf
29 Apr 21
Prospectus supplement
6:10am
S-3
623zdhqt4y4y02
15 Apr 21
Shelf registration
4:03pm
8-K
EX-10.1
ltl8zjmk
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
S-4
EX-2.1
1rst6 o03n5r
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.6
og17y90
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.7
tlbi a7jlxb772
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
qaeala
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
jwuy77dpmlrdw 0c7t
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-1.1
9bnto7j43ckpgwnk8n
14 Feb 19
Current report (foreign)
4:40pm
424B4
j5oq waytkw9cb
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
hfxtnxvdizs
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
1rc oq7sdc037cdwnla7
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
wohlso09m1wo
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
sl03mlqs7o0f1yio440
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.2
mjzj69l 1c
7 Jan 19
Registration statement (foreign)
5:11pm